Brief: Mendus Reports Positive Read-Out For First Stage Vital-Cml Trial
11/09/2026 07:01
BRIEF-Mendus Reports Positive Read-Out For First Stage Vital-Cml Trial Sept 11 (Reuters) - Mendus AB (publ) IMMUN.ST:
MENDUS REPORTS POSITIVE READ-OUT FOR FIRST STAGE VITAL-CML TRIAL
DATA SAFETY MONITORING BOARD FINDS NO SAFETY CONCERNS FOR VIDIDENCEL AND TKI IN FIRST STAGE OF VITAL-CML
Source text: ID:nMFN2cTLpp
Further company coverage: IMMUN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))